Evidence map›Paper›PMID 32311889›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Effect of KIR/HLA receptor-ligand mode on prognosis of single unrelated cord blood transplantation in patients with hematological malignancies].

T T Fang, X Y Zhu, B L Tang, H L Liu, X Wan, K D Song, W Yao, G Y Sun, X C Fang, Z M Sun

Open access · greenAbstract read
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

T T FangDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
X Y ZhuDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
B L TangDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
H L LiuDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
X WanDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
K D SongDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
W YaoDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
G Y SunDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
X C FangDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
Z M SunDepartment of Hematology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China.
Anhui Provincial Hospital · CN

Funding

National Natural Science Foundation of China 81470350The Fundamental Research Funds for the Central Universities WK9110000001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cord Blood Stem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationAdolescentAdultChildChild, PreschoolFemaleHLA AntigensHumansInfantMaleMiddle AgedNeoplasm Recurrence, LocalReceptors, KIRHLA AntigensReceptors, KIRHuman leukocyte antigenKIR ligands absenceNatural killercell immunoglobulin-like receptorsUmbilical cord blood transplantation

Identifiers

PMID32311889
PMCPMC7357922
OpenAlexW3026647045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.